Home
Company
Therapeutic Focus
Pipeline
Oxylanthanum Carbonate (OLC)
UNI-494
Investors
Resources
Contact
RPS: Novel phosphate binder oxylanthanum carbonate effectively reduced serum and urine phosphorus concentrations in animal models